Atlas Trials

Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity

Clinical trial NCT03024957 · UNKNOWN

Trial details

NCT number
NCT03024957
Sponsor
Assiut University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Immune System Suppression
Start date
2017-01-01
Primary completion
2018-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.